For many couples, planning a family begins with conversations about finances, careers, homes, and hopes for the future. Rarely does it start with a discussion about genes. Yet for thousands of families across India, a simple blood test before pregnancy can provide information that may shape important reproductive decisions.
Inherited Blood Disorders: A Silent Genetic Burden
Inherited blood disorders such as thalassaemia and sickle cell disease are among the most common genetic conditions in the country. What makes them particularly challenging is that many carriers appear completely healthy. They often have no symptoms, no warning signs, and no reason to suspect they carry an altered gene until they start planning a pregnancy or a child receives a diagnosis.
That is why health experts increasingly stress the importance of timely screening. Knowing one's carrier status does not create fear; it creates awareness. And awareness gives families the opportunity to plan with confidence rather than react under pressure.
When Good Health Doesn't Tell the Whole Story
One of the biggest misconceptions surrounding inherited blood disorders is that a person who feels healthy cannot possibly be a carrier. According to Dr Navina Singh, Fertility Specialist at Birla Fertility & IVF, Mumbai, this assumption often leads to delayed diagnosis. “Inherited blood disorders such as thalassaemia and sickle cell disease often remain invisible until a family begins planning a pregnancy, or until a child receives a diagnosis. In many cases, carriers are healthy, symptom-free and unaware that they carry an altered gene.”
Conditions such as beta thalassaemia are inherited through what doctors call an autosomal recessive pattern. In simple terms, a child develops the severe form of the disease only if both parents pass on the altered gene. A person carrying only one altered copy of the gene is known as a carrier. Carriers generally live normal, healthy lives. Sometimes routine blood tests may show mild anaemia, but these findings can easily be mistaken for nutritional deficiencies, delaying further investigation. The absence of symptoms does not necessarily mean the absence of risk.
India's Silent Genetic Burden
Inherited blood disorders are often discussed as rare diseases, but the numbers tell a different story. According to the Government of India, thalassaemia remains a significant public health concern. Estimates suggest that between 35 and 45 million Indians are carriers of the beta-thalassaemia trait. For children born with Thalassaemia Major, treatment is not limited to occasional hospital visits. Early screening cannot eliminate every risk, but it can help families understand potential outcomes before pregnancy begins. However, when two carriers have a child together, the risk of passing on a serious blood disorder increases significantly. Experts say timely screening before pregnancy can help couples understand their genetic risks, access counselling, and make informed family planning decisions.
Why Timing Can Change Everything
Many couples first encounter genetic testing during pregnancy. While antenatal screening remains essential, specialists believe conversations about inherited disorders should begin earlier. Dr Singh explained, “When carrier status is identified early, couples have more time to understand their results, speak to a specialist and make informed reproductive decisions with greater clarity.”
Pre-conception screening offers something that pregnancy often does not: time. Time to seek expert advice. Time to understand complex medical information. Time to discuss options without the stress that naturally accompanies pregnancy. The process itself is usually straightforward. Importantly, screening is not designed to create alarm. Its purpose is to provide accurate information. As Dr Singh noted, “The absence of symptoms does not always mean the absence of carrier status. A timely blood test and appropriate counselling can help couples understand whether any inherited risk is relevant to their reproductive planning.”
Understanding the Real Risk, and Avoiding Unnecessary Fear
Genetics can sound intimidating, especially when medical terminology enters the conversation. Yet many fears surrounding inherited blood disorders arise from misunderstanding rather than actual risk. One of the most important facts couples should know is that if only one partner carries a beta-thalassaemia mutation, their child will not develop Thalassaemia Major. The child may become a carrier, but will not inherit the severe disease. This distinction matters. Without proper counselling, couples may assume any positive carrier result automatically means a child will be affected. In reality, risk assessment depends on the genetic status of both partners.
Dr Singh stressed that counselling is just as important as testing itself: “Screening alone is not enough unless couples receive clear, sensitive and practical guidance. Counselling helps explain inheritance patterns, reproductive options and the next steps in a way that is medically accurate and emotionally supportive.” When people understand their results clearly, they are better equipped to make informed decisions rather than fearful ones.
How Modern Reproductive Medicine Is Expanding Choices
Advances in reproductive medicine have created new options for couples who are known carriers of inherited blood disorders. Dr Singh explained, “For couples where both partners carry a beta thalassaemia mutation, reproductive medicine offers additional options. IVF with Preimplantation Genetic Testing for Monogenic Disorders, known as PGT-M, allows embryos created through IVF to be tested for a specific inherited condition before transfer to the uterus.” In the case of beta thalassaemia, the test can help identify embryos that are not affected by Thalassaemia Major before pregnancy is established. This represents a broader role for IVF than many people realise. While often associated with infertility treatment, IVF can also support preventive reproductive planning for certain genetic conditions.
Making Screening a Normal Part of Family Planning
For decades, conversations around pregnancy have focused primarily on maternal health, nutrition, and prenatal care. Increasingly, experts believe genetic awareness deserves a place in those discussions as well. A simple screening test cannot predict every health outcome. It cannot eliminate uncertainty. But it can provide valuable information at a stage when couples have the greatest range of options. Dr Singh summarised the issue clearly: “Timely screening creates informed choices. Screening during pregnancy remains valuable, but screening before conception gives couples more time to understand their results and consider the full range of medical options available to them.”
Medical experts consulted: This article includes expert inputs shared with TOI Health by Dr Navina Singh, Fertility Specialist, Birla Fertility & IVF, Mumbai. Inputs were used to explain how inherited blood disorders such as thalassaemia and sickle cell disease are passed through families, why many carriers remain unaware of their status, and how timely screening before pregnancy can help couples understand genetic risks and make informed family planning decisions.
